Literature DB >> 24476442

Tiotropium and the risk of death in COPD.

Yoon K Loke, Sonal Singh, Curt D Furberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24476442     DOI： 10.1056/NEJMc1314411

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Response to Wise et al. (Tiotropium safety in real life populations).

Authors:  Sven Schmiedl; Petra Thürmann; Rainald Fischer; Dominik Rottenkolber; Marietta Rottenkolber
Journal:  Br J Clin Pharmacol       Date:  2016-05-20       Impact factor: 4.335

Review 2.  Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

Authors:  Gerard J Criner; Jean Bourbeau; Rebecca L Diekemper; Daniel R Ouellette; Donna Goodridge; Paul Hernandez; Kristen Curren; Meyer S Balter; Mohit Bhutani; Pat G Camp; Bartolome R Celli; Gail Dechman; Mark T Dransfield; Stanley B Fiel; Marilyn G Foreman; Nicola A Hanania; Belinda K Ireland; Nathaniel Marchetti; Darcy D Marciniuk; Richard A Mularski; Joseph Ornelas; Jeremy D Road; Michael K Stickland
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

3.  Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.

Authors:  Sven Schmiedl; Rainald Fischer; Luisa Ibanez; Joan Fortuny; Petra Thürmann; Elena Ballarin; Pili Ferrer; Monica Sabaté; Dominik Rottenkolber; Roman Gerlach; Martin Tauscher; Robert Reynolds; Joerg Hasford; Marietta Rottenkolber
Journal:  Br J Clin Pharmacol       Date:  2015-12-23       Impact factor: 4.335

4.  Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.

Authors:  Anthony D D'Urzo; Edward M Kerwin; Kenneth R Chapman; Marc Decramer; Robert DiGiovanni; Peter D'Andrea; Huilin Hu; Pankaj Goyal; Pablo Altman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-11

5.  Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.

Authors:  Donald P Tashkin; Inge Leimer; Norbert Metzdorf; Marc Decramer
Journal:  Respir Res       Date:  2015-06-02

6.  Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study.

Authors:  Francesco Trotta; Stefania Spila-Alegiani; Roberto Da Cas; Maja Rajevic; Valentino Conti; Mauro Venegoni; Mariangela Rossi; Giuseppe Traversa
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.